Skip to main content
Fig. 3 | Renal Replacement Therapy

Fig. 3

From: Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial

Fig. 3

Parathyroid hormone, calcium, and phosphate levels in patients by study week. a Serum-intact parathyroid hormone levels. b Serum-intact parathyroid hormone levels in each group (25, 50, and ≥ 75 mg). c Serum-corrected calcium levels. d Serum-corrected calcium levels in each group (25, 50, and ≥ 75 mg). e Serum phosphate levels. f Serum phosphate levels in each group (25 mg, 50 mg, ≥ 75 mg). Data markers indicate the mean and error bars indicate 95% confidence intervals

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us